Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.com
Investment analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE:BTX opened at $7.00 on Thursday. The firm has a 50-day moving average of $1.75 and a two-hundred day moving […]
